Centocor
Biotechnology monoclonal antibody development
- B2B
About Centocor
A biotechnology company acquired by Johnson & Johnson, specializing in monoclonal antibodies, diagnostics, and biologic agents for various medical conditions globally
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Founded
- 1979
- Revenue
- $21M – $166MTamtam estimate
- Website
- centocor.com
- linkedin.com/company/centocor
Centocor at a glance
Centocor is a B2B company in the Biotechnology Research industry.
Centocor was founded in 1979.
Centocor has 251–1,000 employees.
Centocor's revenue is $21M – $166M (Tamtam estimate).
Selling to companies like Centocor?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies